Edana Cassol Selected Research

Edana Cassol Research Topics

Disease

8	Infections 12/2017 - 11/2006
5	Inflammation (Inflammations) 10/2021 - 05/2013
4	Coinfection 12/2013 - 06/2007
3	HIV Infections (HIV Infection) 11/2021 - 12/2013
3	Acquired Immunodeficiency Syndrome (AIDS) 10/2015 - 06/2007
3	Kaposi Sarcoma (Kaposi's Sarcoma) 06/2007 - 02/2005
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 05/2013
2	Necrosis 10/2015 - 03/2013
2	Opportunistic Infections (Opportunistic Infection) 10/2015 - 06/2007
2	Neurocognitive Disorders (Clerambault Syndrome) 07/2014 - 12/2013
2	Substance-Related Disorders (Drug Abuse) 12/2013 - 01/2012
1	Hypoxia (Hypoxemia) 12/2021
1	Wounds and Injuries (Trauma) 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2018
1	Zika Virus Infection 12/2017
1	Neoplasms (Cancer) 11/2017
1	Obesity 12/2013
1	Non-alcoholic Fatty Liver Disease 05/2013
1	Hepatitis C 05/2013
1	Fibrosis (Cirrhosis) 05/2013
1	Disease Progression 01/2012
1	Tuberculosis (Tuberculoses) 02/2005

Drug/Important Bio-Agent (IBA)

5	CytokinesIBA 12/2021 - 05/2009
4	Biomarkers (Surrogate Marker)IBA 07/2014 - 01/2012
3	Proteins (Proteins, Gene)FDA Link 11/2021 - 07/2013
2	InterleukinsIBA 10/2015 - 07/2014
2	ChemokinesIBA 10/2015 - 12/2013
2	LipopolysaccharidesIBA 10/2015 - 05/2013
2	LigandsIBA 10/2015 - 05/2013
2	Tryptophan (L-Tryptophan)FDA Link 05/2015 - 07/2014
2	Interleukin-6 (Interleukin 6)IBA 07/2014 - 09/2010
2	Lipopolysaccharide ReceptorsIBA 12/2013 - 01/2012
2	Interferon-gamma (Interferon, gamma)IBA 07/2013 - 03/2013
1	Glucose (Dextrose)FDA LinkGeneric 12/2021
1	CaspasesIBA 10/2021
1	NADP (NADPH)IBA 01/2021
1	Flavin-Adenine Dinucleotide (FAD)IBA 01/2021
1	NAD (NADH)IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Particulate MatterIBA 12/2018
1	Viral ProteinsIBA 12/2017
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 10/2015
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 10/2015
1	Transcription Factors (Transcription Factor)IBA 10/2015
1	CXC ChemokinesIBA 10/2015
1	CC ChemokinesIBA 10/2015
1	Messenger RNA (mRNA)IBA 10/2015
1	Biological ProductsIBA 05/2015
1	KynurenineIBA 07/2014
1	InterferonsIBA 07/2014
1	Glutamic Acid (Glutamate)FDA Link 07/2014
1	Reverse Transcriptase InhibitorsIBA 10/2013
1	NucleosidesIBA 10/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2013
1	vesicular stomatitis virus G proteinIBA 07/2013
1	SteroidsIBA 05/2013
1	LipidsIBA 05/2013
1	EicosanoidsIBA 05/2013
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 05/2013
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 05/2013
1	BilirubinIBA 05/2013
1	Bile Acids and Salts (Bile Acids)IBA 05/2013
1	lipopolysaccharide-binding proteinIBA 05/2013
1	Protease Inhibitors (Protease Inhibitor)IBA 05/2013
1	Interleukin-4 (Interleukin 4)IBA 03/2013
1	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 03/2013
1	Intercellular Adhesion Molecule-3IBA 03/2013
1	RNA (Ribonucleic Acid)IBA 06/2007
1	Antiviral Agents (Antivirals)IBA 06/2007
1	Chemokine ReceptorsIBA 11/2006
1	Lamivudine (Epivir)FDA Link 02/2005
1	efavirenz (Sustiva)FDA Link 02/2005
1	Stavudine (Zerit)FDA LinkGeneric 02/2005
1	Didanosine (Videx)FDA LinkGeneric 02/2005
1	Nevirapine (Viramune)FDA Link 02/2005

Therapy/Procedure

5	Highly Active Antiretroviral Therapy (HAART) 01/2014 - 03/2005
4	Therapeutics 01/2021 - 11/2017
2	Art Therapy 07/2014 - 12/2013
1	Drug Therapy (Chemotherapy) 06/2007